Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regeneration

Biomaterials

Volumn 27, Issue 36, 2006, Pages 6102-6110

  Benoit, Danielle S W ^a   Nuttelman, Charles R ^a   Collins, Stuart D ^a   Anseth, Kristi S ^a,b  

^a UCB 450   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Bone tissue engineering; Controlled drug release; Mesenchymal stem cells; Statin

Indexed keywords

BONE TISSUE ENGINEERING; CONTROLLED DRUG RELEASE; MESENCHYMAL STEM CELLS; STATIN;

BONE; ESTERS; HYDROGELS; HYDROLYSIS; SYNTHESIS (CHEMICAL);

CONTROLLED DRUG DELIVERY;

BONE MORPHOGENETIC PROTEIN 2; DRUG CARRIER; FLUINDOSTATIN; LACTIC ACID; MACROGOL; METHACRYLIC ACID DERIVATIVE; POLYMER;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; DRUG SYNTHESIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYDROGEL; HYDROLYSIS; POLYMERIZATION; PRIORITY JOURNAL; TISSUE ENGINEERING;

BIOCOMPATIBLE MATERIALS; BONE REGENERATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; FATTY ACIDS, MONOUNSATURATED; HUMANS; HYDROGELS; INDOLES; MATERIALS TESTING; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; TISSUE ENGINEERING;

HARNESS;

EID: 33748805769     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.06.031     Document Type: Article

References (24)

1. Govender S., Csimma C., Genant H.K., and Valentin-Opran A. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures-a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg 84A (2002) 2123-2134
2. Groeneveld E.H.J., and Burger E.H. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142 (2000) 9-21
3. Lane J.M. BMPs: why are they not in everyday use?. J Bone Joint Surg 83A (2001) S161-S163
4. Farnier M., and Davignon J. Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol 82 (1998) 3J-10J
5. Maeda T., Matsunuma A., Kawane T., and Horiuchi N. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Comm 280 (2001) 874-877
6. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 286 (1999) 1946-1949
7. Sugiyama M., Kodama T., Konishi K., Abe K., Asami S., and Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Comm 271 (2000) 688-692
8. Cummings S.R., and Bauer D.C. Do statins prevent both cardiovascular disease and fracture?. J Am Med Assoc 283 (2000) 3255-3257
9. Meier C.R., Schlienger R.G., Kraenzlin M.E., Schlegel B., and Jick H. HMG-CoA reductase inhibitors and the risk of fractures. J Am Med Assoc 283 (2000) 3205-3210
10. Wang P.S., Solomon D.H., Mogun H., and Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. J Am Med Assoc 283 (2000) 3211-3216
11. Whang K.M., McDonald J., Khan A., and Satsangi N. A novel osteotropic biomaterial OG-PLG: synthesis and in vitro release. J Biomed Mater Res A 74A (2005) 237-246
12. Service R.F. Tissue engineers build new bone. Science 289 (2000) 1498-1500
13. Haberstadt C., Anderson P., Bartel R., Cohen R., and Naughton G. Physiological cultured skin substitutes for wound healing. Mater Res Soc Symp Proc 252 (1992) 323-330
14. Nuttelman C.R., Tripodi M.T., and Anseth K.S. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs. J Biomed Mater Res A 76A (2006) 183-195
15. Kim H., Kim H.W., and Suh H. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials 24 (2003) 4671-4679
16. Sawhney A.S., Pathak C.P., and Hubbell J.A. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(alpha-hydroxy acid) diacrylate macromers. Macromolecules 26 (1993) 581-587
17. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
18. Stein G.S., and Lian J.B. Molecular mechanism mediating proliferation, defferentiation interrelationships during progressing development of the osteoblast phenotype. Endocrine Rev 14 (1993) 424-442
19. Siparsky G.L., Voorhees K.J., and Miao F.D. Hydrolysis of polylactic acid (PLA) and polycaprolactone (PCL) in aqueous acetonitrile solutions: autocatalysis. J Environ Polymer Deg 6 (1998) 31-41
20. Carvalheira A.F., and Pearse A.G.E. Comparative cytochemistry of C cell esterases in the mammalian thyroid-parathyroid complex. Histochem Cell Biol 8 (1967) 175-182
21. Metters A.T., Anseth K.S., and Bowman C.N. Fundamental studies of a novel, biodegradable PEG-b-PLA hydrogel. Polymer 41 (2000) 3993-4004
22. Bryant S.J., and Anseth K.S. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J Biomed Mater Res A 64A (2003) 70-79
23. Shih C. Chain-end scission in acid-catalyzed hydrolysis of poly(d,l-lactic acid units) in solution. J Controlled Rel 34 (1995) 9-15
24. Hu D.S.G., and Liu H.J. Effect of soft segment on degradation kinetics in polyethylene glycol/poly(l-lactic acid units) block-copolymers. Polym Bullet 30 (1993) 669-676